Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 159786, 11 pages
http://dx.doi.org/10.1155/2013/159786
Research Article

Gemifloxacin, a Fluoroquinolone Antimicrobial Drug, Inhibits Migration and Invasion of Human Colon Cancer Cells

1Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
2Department of Surgery, Division of Gastrointestinal and General Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
3Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
4Department of Internal Medicine, Division of Infectious Diseases, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
5Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
6Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
7Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan

Received 17 September 2013; Revised 16 November 2013; Accepted 18 November 2013

Academic Editor: Chih-Hsin Tang

Copyright © 2013 Jung-Yu Kan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Gribovskaja-Rupp, L. Kosinski, and K. A. Ludwig, “Obesity and colorectal cancer,” Clinics in Colon and Rectal Surgery, vol. 24, no. 4, pp. 229–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics for Hispanics/Latinos, 2012,” CA: Cancer Journal for Clinicians, vol. 62, no. 5, pp. 283–298, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. F. J. van Duijnhoven, H. B. Bueno-De-Mesquita, P. Ferrari et al., “Fruit, vegetables, and colorectal cancer risk: the European prospective investigation into cancer and nutrition,” The American Journal of Clinical Nutrition, vol. 89, no. 5, pp. 1441–1452, 2009. View at Publisher · View at Google Scholar
  4. V. A. Mccormack and P. Boffetta, “Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries,” Annals of Oncology, vol. 22, no. 11, pp. 2349–2357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Hu, A. Krasinskas, and J. Willis, “Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum,” Seminars in Oncology, vol. 38, no. 4, pp. 500–510, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L. C. Moreau, R. Rajan, M. P. Thirlwell, and T. Alcindor, “Response to chemotherapy in metastatic colorectal cancer after exposure to oxaliplatin in the adjuvant setting,” Anticancer Research, vol. 33, no. 4, pp. 1765–1768, 2013. View at Google Scholar
  7. T. Cooks, I. S. Pateras, O. Tarcic et al., “Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer,” Cancer Cell, vol. 23, no. 5, pp. 634–646, 2013. View at Publisher · View at Google Scholar
  8. H. Shaked, L. J. Hofseth, A. Chumanevich et al., “Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 35, pp. 14007–14012, 2012. View at Publisher · View at Google Scholar
  9. J. Daniluk, Y. Liu, D. Deng et al., “An NF-κB pathway-mediated positive feedback loop amplifies Ras activity to pathological levels in mice,” Journal of Clinical Investigation, vol. 122, no. 4, pp. 1519–1528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Z. Yang, C. Li, X. Wang et al., “Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-κB signaling pathway in colon cancer cells,” Journal of Cellular Physiology, vol. 225, no. 1, pp. 266–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Kroepil, G. Fluegen, Z. Totikov et al., “Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas,” PLoS ONE, vol. 7, no. 9, Article ID e46665, 2012. View at Publisher · View at Google Scholar
  12. P. Yue, X. Zhang, D. Paladino et al., “Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells,” Oncogene, vol. 31, pp. 2309–2322, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Peña, J. M. García, M. J. Larriba et al., “SNAI1 expression in colon cancer related with CDH1 and VDR downregulation in normal adjacent tissue,” Oncogene, vol. 28, no. 49, pp. 4375–4385, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-L. Hsu, C.-Y. Chen, I.-P. Lin, E.-M. Tsai, P.-L. Kuo, and M.-F. Hou, “4-Shogaol, an active constituent of dietary ginger, inhibits metastasis of MDA-MB-231 human breast adenocarcinoma cells by decreasing the repression of NF-κB/Snail on RKIP,” Journal of Agricultural and Food Chemistry, vol. 60, no. 3, pp. 852–861, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. N. Richter, G. Giaretta, V. Comuzzi et al., “Hot-spot consensus of fluoroquinolone-mediated DNA cleavage by Gram-negative and Gram-positive type II DNA topoisomerases,” Nucleic Acids Research, vol. 35, no. 18, pp. 6075–6085, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. G. G. Zhanel, S. Fontaine, H. Adam et al., “A review of new fluoroquinolones: focus on their use in respiratory tract infections,” Treatments in Respiratory Medicine, vol. 5, no. 6, pp. 437–465, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Yadav, S. Sultana, J. Yadav, and N. Saini, “Gatifloxacin induces S and G2-phase cell cycle arrest in pancreatic cancer cells via p21/p27/p53,” PLoS ONE, vol. 7, no. 10, Article ID e47796, 2012. View at Publisher · View at Google Scholar
  18. T. Kloskowski, N. Gurtowska, J. Olkowska et al., “Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC,” International Journal of Oncology, vol. 41, no. 6, pp. 1943–1949, 2012. View at Publisher · View at Google Scholar
  19. K. W. Seo, R. Holt, Y. S. Jung, C. O. Rodriguez Jr., X. Chen, and R. B. Rebhun, “Fluoroquinolone-mediated inhibition of cell growth, S-G2/M cell cycle arrest, and apoptosis in canine osteosarcoma cell lines,” PLoS ONE, vol. 7, no. 8, Article ID e42960, 2012. View at Publisher · View at Google Scholar
  20. H. Ogino, M. Fujii, M. Ono, K. Maezawa, S. Hori, and J. Kizu, “In vivo and in vitro effects of fluoroquinolones on lipopolysaccharide- induced pro-inflammatory cytokine production,” Journal of Infection and Chemotherapy, vol. 15, no. 3, pp. 168–173, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Hugo, M. L. Ackland, T. Blick et al., “Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression,” Journal of Cellular Physiology, vol. 213, no. 2, pp. 374–383, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Umar, S. Sarkar, S. Cowey, and P. Singh, “Activation of NF-κB is required for mediating proliferative and antiapoptotic effects of progastrin on proximal colonic crypts of mice, in vivo,” Oncogene, vol. 27, no. 42, pp. 5599–5611, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. S. Jain and R. P. Bird, “Elevated expression of tumor necrosis factor-alpha signaling molecules in colonic tumors of Zucker obese (fa/fa) rats,” International Journal of Cancer, vol. 127, no. 9, pp. 2042–2050, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Garattini and V. Bertelé, “Risk: benefit assessment of old medicines,” British Journal of Clinical Pharmacology, vol. 58, no. 6, pp. 581–586, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. T. W. Li, H. Yang, H. Peng, M. Xia, J. M. Mato, and S. C. Lu, “Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice,” Carcinogenesis, vol. 33, no. 2, pp. 427–435, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Schwitalla, A. A. Fingerle, P. Cammareri et al., “Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties,” Cell, vol. 152, pp. 25–38, 2013. View at Google Scholar
  27. I. C. Allen, J. E. Wilson, M. Schneider et al., “NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling,” Immunity, vol. 36, no. 5, pp. 742–754, 2012. View at Publisher · View at Google Scholar
  28. X. Li, L. Gao, Q. Cui et al., “Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs,” Oncogene, vol. 31, pp. 4979–4986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Liu, Y. H. Li, Y. B. Niu et al., “An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-κB pathway in a mouse model of colitis-associated colon cancer,” Carcinogenesis, vol. 31, no. 10, pp. 1822–1832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. K. L. Edelblum, J. A. Goettel, T. Koyama, S. J. Mcelroy, F. Yan, and D. B. Polk, “TNFR1 promotes tumor necrosis factor-mediated mouse colon epithelial cell survival through RAF activation of NF-κB,” The Journal of Biological Chemistry, vol. 283, no. 43, pp. 29485–29494, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J.-S. Shin, S.-J. Park, S. Ryu et al., “Potent anti-inflammatory effect of a novel furan-2,5-dione derivative, BPD, mediated by dual suppression of COX-2 activity and LPS-induced inflammatory gene expression via NF-κB inactivation,” British Journal of Pharmacology, vol. 165, no. 6, pp. 1926–1940, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Sung, M. K. Pandey, and B. B. Aggarwal, “Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-κB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IκBα kinase activation,” Molecular Pharmacology, vol. 71, no. 6, pp. 1703–1714, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Hwang, M. Yang, M. Tsai et al., “SNAIL regulates interleukin-8 expression, stem cell—like activity, and tumorigenicity of human colorectal carcinoma cells,” Gastroenterology, vol. 141, no. 1, pp. 279–291, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. H. K. Roy, T. C. Smyrk, J. Koetsier, T. A. Victor, and R. K. Wali, “The transcriptional repressor SNAIL is overexpressed in human colon cancer,” Digestive Diseases and Sciences, vol. 50, no. 1, pp. 42–46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Wu, J. Deng, P. G. Rychahou, S. Qiu, B. M. Evers, and B. P. Zhou, “Stabilization of snail by NF-κB is required for inflammation-induced cell migration and invasion,” Cancer Cell, vol. 15, no. 5, pp. 416–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Karamitopoulou, I. Zlobec, E. Patsouris, G. Peros, and A. Lugli, “Loss of E-cadherin independently predicts the lymph node status in colorectal cancer,” Pathology, vol. 43, no. 2, pp. 133–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Peiró, M. Escrivà, I. Puig et al., “Snail1 transcriptional repressor binds to its own promoter and controls its expression,” Nucleic Acids Research, vol. 34, no. 7, pp. 2077–2084, 2006. View at Publisher · View at Google Scholar
  38. M. D. Amatangelo, S. Goodyear, D. Varma, and M. E. Stearns, “C-Myc expression and MEK1-induced Erk2 nuclear localization are required for TGF-beta induced epithelial-mesenchymal transition and invasion in prostate cancer,” Carcinogenesis, vol. 33, pp. 1965–1975, 2012. View at Google Scholar